MABXIENCE
DEAD

Serial Number

79975374

Owner

MABXIENCE RESEARCH, S.L.

Attorney

Vivian Ortiz-Ponce

Filing Date

Jul 28, 2016

Add to watchlist:

No watchlists yet
View on USPTO

MABXIENCE Trademark

Serial Number: 79975374 • Registration: 5472348

MABXIENCE is a trademark filed by MABXIENCE RESEARCH, S.L. on July 28, 2016. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

MABXIENCE RESEARCH, S.L. (16 trademarks)

C/ Manuel Pombo Angulo, 28 3ª. Planta

Entity Type: 99

Trademark Details

Filing Date

July 28, 2016

Registration Date

May 22, 2018

Published for Opposition

March 6, 2018

Cancellation Date

December 6, 2024

Goods & Services

Pharmaceutical preparations for the treatment of ophthalmic diseases and disorders, dermatological diseases and disorders, pharmaceutical preparations for use in treating digestive diseases and disorders, gynecological diseases and disorders, hormonal diseases and disorders, blood disorders, cancer, cardiovascular diseases, vascular diseases, gastrointestinal diseases, genitourinary diseases, genitourinary disorders, immunologic diseases, infectious diseases, inflammatory diseases, metabolic diseases and disorders, neurological diseases, psychiatric diseases, central nervous system; pharmaceutical preparations for the treatment of diseases of the musculoskeletal system, diseases of the respiratory system, circulatory system, circulatory diseases, viral diseases, glaucoma, dental and oral diseases, headaches, migraine, obesity, hepatic treatments, treatment of the liver, cholesterol, blood pressure and rheumatic treatments; veterinary preparations for treating digestive diseases and disorders, gynecological diseases and disorders, blood disorders, cancer, cardiovascular diseases, vascular diseases, gastrointestinal diseases, genitourinary diseases, immunologic diseases, infectious diseases, inflammatory diseases, metabolic diseases and disorders, neurological diseases, central nervous system, musculoskeletal system, respiratory system, circulatory system, viral diseases, glaucoma, dental and oral diseases, headaches, migraine, obesity, hepatic treatments, cholesterol, blood pressure and rheumatic treatments, and dietetic foods adapted for medical use, namely, breads, pastas, crackers, chips, packaged meals, nutritional food bars, candy, dips, sauces and food supplements in pill, powder capsule, beverage form, effervescent tablet and liquid form

Chemical, biological and pharmaceutical research services

Filing History

TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Aug 6, 2025 INTR
CANCELLED SECTION 71
Dec 6, 2024 C71T
INTERNATIONAL REGISTRATION RENEWED
Sep 26, 2022 RNWL
FINAL DECISION TRANSACTION PROCESSED BY IB
Sep 21, 2018 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Aug 30, 2018 FICS
FINAL DISPOSITION PROCESSED
Aug 30, 2018 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Aug 22, 2018 FICR
REGISTERED-PRINCIPAL REGISTER
May 22, 2018 R.PR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
May 11, 2018 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 25, 2018 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Apr 25, 2018 OPNR
NOTIFICATION PROCESSED BY IB
Mar 16, 2018 GPNX
NOTIFICATION PROCESSED BY IB
Mar 9, 2018 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 6, 2018 NPUB
PUBLISHED FOR OPPOSITION
Mar 6, 2018 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Feb 14, 2018 OPNS
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 14, 2018 NONP
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Feb 14, 2018 OP2R
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 30, 2018 CNSA
NOTICE OF DIVIDED TRADEMARK APPLICATION MAILED
Jan 23, 2018 MNDA
DIVISIONAL PROCESSING COMPLETE
Jan 19, 2018 DPCC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jan 16, 2018 AITU
ASSIGNED TO LIE
Jan 11, 2018 ALIE
EX PARTE APPEAL-INSTITUTED
Dec 28, 2017 EXPI
JURISDICTION RESTORED TO EXAMINING ATTORNEY
Dec 28, 2017 JURT
EXPARTE APPEAL RECEIVED AT TTAB
Dec 28, 2017 EXAF
DIVISIONAL REQUEST RECEIVED
Dec 27, 2017 DRRR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Dec 27, 2017 ERFR
TEAS REQUEST TO DIVIDE RECEIVED
Dec 27, 2017 ERTD
NOTIFICATION OF FINAL REFUSAL EMAILED
Jun 27, 2017 GNFN
FINAL REFUSAL E-MAILED
Jun 27, 2017 GNFR
FINAL REFUSAL WRITTEN
Jun 27, 2017 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 6, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 5, 2017 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 5, 2017 TROA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 5, 2017 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 5, 2017 REAP
CHANGE OF OWNER RECEIVED FROM IB
Jan 5, 2017 CHLD
REFUSAL PROCESSED BY IB
Dec 30, 2016 RFNP
APPLICATION FILING RECEIPT MAILED
Dec 6, 2016 MAFR
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Dec 5, 2016 RFCS
REFUSAL PROCESSED BY MPU
Dec 5, 2016 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 3, 2016 RFCR
NON-FINAL ACTION WRITTEN
Dec 2, 2016 CNRT
ASSIGNED TO EXAMINER
Dec 1, 2016 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 1, 2016 NWOS
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Nov 24, 2016 SDRC